A0A045J9I4 (A0A045J9I4_MYCTX) Mycobacterium tuberculosis
Oxidoreductase, FAD-binding UniProtKBInterProSTRINGSTRINGInteractive Modelling
461 aa; Sequence (Fasta) ;
10 identical sequences: Mycobacterium tuberculosis: P9WJF1, P9WJF0; Mycobacterium tuberculosis variant africanum K85: A0A9P2H4C2; Mycobacterium tuberculosis: A5U9B9; Mycobacterium bovis: A0A0H3MC09; Mycobacterium tuberculosis variant africanum: U5JD70; Mycobacterium bovis: A0A1R3Y598, A0AA34Y9W2; Mycobacterium orygis 112400015: A0A829C4V3; Mycobacterium tuberculosis variant bovis BCG str. Korea 1168P: A0A7U4FC20
It is possible new templates exist for this target since these models were created.
Available Structures
19 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of M. tuberculosis DprE1 in complex with PBTZ169 | monomer | 1×26J; 1×FAD; 3×GOL; | ||||
| Assess | ||||||
| Mycobacterium tuberculosis DprE1 mutant Y314C in complex with TCA1 | monomer | 1×FAD; 1×1W6; | ||||
| Assess | ||||||
| Crystal structure of M. tuberculosis DprE1 in complex with the non-covalent inhibitor QN129 | monomer | 1×FAD; 1×R26; 1×IMD; 1×2J3; | ||||
| Assess | ||||||
| Mycobacterium tuberculosis DprE1 - hexagonal crystal form | monomer | 1×FAD; | ||||
| Assess | ||||||
| Mycobacterium tuberculosis DprE1 in complex with CMP2 | monomer | 1×FAD; 1×IMD; 1×G1T; | ||||
| Assess | ||||||
| M tuberculosis DprE1 in complex with a covalently bound nitrobenzothiazinone | monomer | 1×26J; 1×FAD; | ||||
| Assess | ||||||
| Mycobacterium tuberculosis DprE1 - monoclinic crystal form | monomer | 1×FAD; 1×IMD; | ||||
| Assess | ||||||
| Mycobacterium tuberculosis DprE1 in complex with inhibitor TCA020 | monomer | 1×FAD; 1×P95; 1×IMD; | ||||
| Assess | ||||||
| Crystal structure of M. tuberculosis in complex with a cBT - non-covalent adduct | monomer | 1×FAD; 1×IMD; 1×2R2; | ||||
| Assess | ||||||
| M tuberculosis DprE1 in complex with BTZ043 | monomer | 1×0SK; 1×FAD; 1×IMD; | ||||
| Assess | ||||||
| Mycobacterium tuberculosis DprE1 in complex with inhibitor TCA481 | monomer | 1×FAD; 1×9T2; 1×IMD; | ||||
| Assess | ||||||
| M. tuberculosis DprE1 covalently bound to a nitrobenzoxacinone. | monomer | 1×FAD; 1×G1H; | ||||
| Assess | ||||||
| Mycobacterium tuberculosis DprE1 in complex with CT325 - hexagonal crystal form | monomer | 1×FAD; 1×0T4; | ||||
| Assess | ||||||
| Mycobacterium tuberculosis DprE1 in complex with CT319 | monomer | 1×FAD; 1×0T5; | ||||
| Assess | ||||||
| Mycobacterium tuberculosis DprE1 in complex with CMP1 | monomer | 1×FAD; 1×IMD; 1×G1T; | ||||
| Assess | ||||||
| Mycobacterium tuberculosis DprE1 in complex with CT325 - monoclinic crystal form | monomer | 1×FAD; 1×0T4; 2×IMD; | ||||
| Assess | ||||||
| Crystal structure of M. tuberculosis DprE1 in complex with sPBTZ169 (sulfonylPBTZ) | monomer | 1×FAD; 1×EQ8; | ||||
| Assess | ||||||
| Crystal structure of M. tuberculosis in complex with BTO - covalent adduct | monomer | 1×FAD; 1×N77; | ||||
| Assess | ||||||
| Crystal structure of M. tuberculosis DprE1 in complex with the nitro-benzothiazole 6a | monomer | 1×FAD; 1×O95; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4p8c.1.A | monomer | 0.91 | 1×FAD; 1×Y22; 1×2J3; | 100.00 | ||
| Assess | ||||||